DigestRedComo funciona
Red
/
Empresas
Se
No verificado

Sensorion

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

53 Comunicados de prensa

Ver todos los comunicados de prensa
23/09/2026
Mercado de valores
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Sensorion Reports 2026 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
Fuente
Sensorion
Editor
Business Wire
1.00
0
18/09/2026
Web y redes sociales
Industria
Eventos
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Sensorion Announces Connection Details for its SENS-601 Program Day on September 22, 2026
Fuente
Sensorion
Editor
Business Wire
1.00
0
16/09/2026
Biotecnología
Sanidad
Farmacéutica
Salud
Sensorion Announces Confidential Submission of Draft Registration Statement to the SEC for Potential U.S. Initial Public Offering
Fuente
Sensorion
Editor
Business Wire
1.00
0
15/09/2026
Finanzas
Salud
Ir de compras
Biotecnología
Farmacéutica
Sensorion Announces the Completion of Its Reverse Share Split
Fuente
Sensorion
Editor
Business Wire
1.00
0
03/09/2026
Industria
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Sensorion Announces Approval of Clinical Trial Application in France for SENS-601, Its Investigational Gene Therapy for the Treatment of GJB2-Related Hearing Loss
Fuente
Sensorion
Editor
Business Wire
1.00
0
29/07/2026
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Finanzas
Sensorion Announces a Reverse Share Split of its Shares
Fuente
Sensorion
Editor
Business Wire
1.00
0
10/06/2026
Ciencia
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Industria
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
Fuente
Sensorion
Editor
Business Wire
1.00
0
10/06/2026
Ciencia
Farmacéutica
Sanidad
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Industria
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
Fuente
Sensorion
Editor
Business Wire
1.00
0
18/05/2026
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Mercado laboral
Sensorion Appoints Fred Chereau as Chief Executive Officer
Fuente
Sensorion
Editor
Business Wire
1.00
0
05/05/2026
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Eventos
Sensorion Announces its Participation in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fuente
Sensorion
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0